RxDoctor Payments Data

Maharshi Rajdev, MD

Vascular & Interventional Radiology · Rochester, MNNPI 1427412014

Payments from drug & device makers

What this record shows

Medtronic accounts for 77.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $1,390 and has fallen 91.0% since, to $125 in 2025. That places this record below the midpoint for vascular & interventional radiology clinicians in MN, where the typical reported total is $1,967.

$1,774in general payments, 2019–2025

Across 18 payments — averaging $98.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$1K
  • Boston Scientific$169
  • Bard Peripheral Vascular, Inc.$85
  • Baxter Healthcare$81
  • Argon Medical Devices, Inc.$36
  • Cordis US CORP.$32

What the payments were for

  • Travel & lodging$88450%
  • Food & beverage$89050%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,774 in reported general payments places this provider in the 45th percentile of 78 vascular & interventional radiology providers in Minnesota.

See all vascular & interventional radiology providers in Minnesota

Medicare billing

Part B allowed, 2024
$207,445
Medicare patients
884
Services billed
5,453

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone14$89

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Rochester

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →